Chandra Vargeese's most recent trade in Wave Life Sciences Ltd. was a trade of 91,754 Ordinary Shares done at an average price of $2.5 . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Mar 2025 | 91,754 | 362,687 (1%) | 0% | 2.5 | 227,550 | Ordinary Shares |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 75,332 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 16,422 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 224,000 | 224,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 37,000 | 270,933 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 23 Jan 2025 | 46,000 | 233,933 (0%) | 0% | 2.5 | 114,080 | Ordinary Shares |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 46,000 | 16,422 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2024 | 68,210 | 75,332 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 22 Jul 2024 | 68,210 | 185,061 (0%) | 0% | 2.5 | 169,161 | Ordinary Shares |
| Wave Life Sciences Ltd. | Vargeese Chandra | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 361,700 | 361,700 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 295,400 | 295,400 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 16 Feb 2023 | 10,249 | 106,624 (0%) | 0% | 4.0 | 41,303 | Ordinary Shares |
| Wave Life Sciences Ltd. | Chandra Vargeese | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 60,000 | 60,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 16 Feb 2022 | 10,603 | 77,809 (0%) | 0% | 2.3 | 24,599 | Ordinary Shares |
| Wave Life Sciences Ltd. | Chandra Vargeese | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 200,000 | 200,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 50,000 | 50,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd. | Chandra Vargeese | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 50,000 | 88,557 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd. | Chandra Vargeese | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.57 per share. | 01 Feb 2021 | 3,145 | 85,412 (0%) | 0% | 10.6 | 33,243 | Ordinary Shares |